Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements clinical trial longevity nad+ nootropics
Approach: conceptual metaphor. Palette: D, bold color field. Subject: a single old-fashioned mechanical light switch, photographed straight on, with its toggle stuck halfway between on and off. It is mounted on a saturated mustard-yellow painted wall. A thin electric green (#00e676) glow leaks from the gap behind the toggle and casts a small green rim onto the plate. Beside it, a row of six small matte black tally marks is scratched into the paint, with the third and fifth marks fainter and partly worn, hinting at inconsistent results across days. Camera: slightly low, eye-level angle with a 50mm lens, shallow depth of field, and the switch placed on the right third of the frame. Lighting: hard directional side light from the left casts crisp, warm-neutral shadows with no blue cast. The wall texture and brushstrokes are visible. Mood: curious, skeptical, and measured. The scene suggests a mechanism that is partly engaged.
Longevity

Diet Mirip Puasa Ngedongkrak Autophagy Manungsa—Nanging Ora Saben Wektu

Helix Ward · · 5 min read
#clinical trial #longevity #autophagy #insulin resistance #intermittent fasting #fasting mimicking diet #prolon

Diet Mirip Puasa Ngedongkrak Autophagy Manungsa—Nanging Ora Saben Wektu

Ringkesan: Apa diet mirip puasa (FMD) pancen isa ngaktifake proses pembersihan sel dhewe, utawa mung fenomena ing tikus? Sawijining uji coba acak pilot sing melu 30 relawan sehat ngetes ProLon lan FMD2 dibandhingake karo grup kontrol. Sawisé kira‑kira enem dina, loro grup nuduhaké owah‑owahan ing aliran autophagy, bobot awak, glukosa, keton, lan resistensi insulin. Nanging perbedaan kuwi ora konsisten ing saben wektu, lan uji coba cilik iki disponsori dening produsen ProLon. Kene carane protokol ditindakake, apa asil sing ditemokaké, lan sapa sing kudu mikir kaping pindho sadurunge nyoba.

Apa bener sawetara dina mangan sethithik bisa nyurung sistem pembersihan sel?

Janji iki dadi pondasi diet mirip puasa (FMD), nanging nganti saiki bukti paling akeh isih saka studi ing tikus lan sel. Sawijining uji coba acak pilot anyar sing diterbitake ing Geroscience nyoba konsep iki ing manungsa. Jawabane? "Mungkin, nanging mung ing wektu‑waktu tartamtu."

Ringkesan Cekak

  • Apa sing diuji: Loro formulasi oral FMD (ProLon lan FMD2) dibandhingake karo grup kontrol.
  • Sapa sing melu: 30 wong sehat kanthi umur rata‑rata 49 taun.
  • Temuan utama: Sawisé kira‑kira enem dina intervensi, grup FMD nuduhaké penurunan bobot awak, glukosa puasa, beta‑hidroksibutirat (BHB, keton), lan indeks resistensi insulin (HOMA‑IR), sarta peningkatan aliran autophagy.
  • Cathetan penting: Bedane ora signifikán ing saben titik wektu. Iki uji coba cilik, cekak, lan disponsori dening perusahaan sing ngasilaké ProLon.

Napa Autophagy Angel Diukur ing Manungsa

Autophagy iku proses sel ngrusak lan daur ulang komponèn sing rusak. Proses iki dadi sorotan riset umur panjang, lan puasa dadi pemicu paling misuwur ing kéwan. Nanging, ngukur siji marker ing gambar getih bisa ngapusi. Protein LC3B, contoné, bisa akumulasi amarga autophagy nggandhol utawa amarga sistem degradasi sel kelem.

Peneliti ngatasi iki kanthi ngukur aliran autophagy (autophagic flux), yaiku kecepatan sesungguhé saka proses. Wong-wong iki misahaké sel imun saka darah (peripheral blood mononuclear cells – PBMC) lan ngolah conto nganggo chloroquine ing laboratorium. Chloroquine ngentekaké langkah pungkasan degradasi, mula akumulasi LC3B‑II dibandhingake LC3B‑I nuduhaké pintén lalu lintas sing liwat jalur iki. Iki cara standar ngukur flux, nanging watesané mung ngukur autophagy ing sel imun sirkulasi, ora ing ati, otot, utawa otak.

Protokol, Langkah demi Langkah

Informasi saka abstrak artikel:

  • Desain: Pilot uji klinis acak, 30 peserta sehat, telung cabang (ProLon, FMD2, kontrol).
  • Kerangka wektu: 8 dina total.
  • Intervensi diet: Abstrak nyebut periode intervensi 6 dina kanggo perbandingan utama. Iki rada luwih suwe tinimbang siklus 5 dina sing biasané digandhengake karo ProLon sing diciptakaké déning Valter Longo, mula aja ngira‑ngira protokol 5 dina sing diuji iki.
  • Pengambilan sampel darah: Baseline, dina 4, dina 6, lan 48 jam sawisé rampung FMD (dina 8).
  • Outcome: Aliran autophagy (rasio LC3B‑II/LC3B‑I karo chloroquine ex‑vivo), glukosa puasa, insulin, IGF‑1, BHB, lan HOMA‑IR.
  • Statistik: One‑way ANOVA utawa tes Kruskal‑Wallis kanggo mbandhingaké grup ing saben wektu lan perubahan saka baseline.

Abstrak ora nyebut target kalori utawa rincian makronutrien. Materi ProLon sing dipasaraké sadurungé nyebutaké rencana bertahap, berbasis tanduran, lan rendah kalori, nanging kanggo rincian sing pas kudu dipriksa pandhuan produk utawa manuskrip lengkap.

Apa Hasilé Ngandharaké lan Apa Ora Ngandharaké

Ing pungkasan intervensi, grup FMD béda saka kontrol ing arah sing dikarepake saka pola mirip puasa. Bobot, glukosa, lan resistensi insulin mudhun, keton mundhak, lan aliran autophagy nambah. Penulis nyimpulaké yèn FMD "bisa ningkatake aliran autophagy lan marker kesehatan metabolik" lan bisa dadi cara non‑farmakologis kanggo ngatur autophagy.

Nanging, ana qualifier penting ing abstrak: bedane ora signifikan ing kabeh titik wektu. Tegese efek mung katon ing jendela wektu tartamtu, paling jelas ing akhir diet. Iki ora nuduhaké owah‑owahan sing lestari. Abstrak uga ora ngomong apa manfaat iki tetep nganti rong dina sawisé diet rampung, mula klaim jangka panjang kudu dianggep ngarep‑arep.

Uga, iki dudu bukti manfaat jangka panjang. Uji coba iki mung ngukur biomarker jangka cekak ing wong sehat, tanpa nyawiji asil klinis kaya penyakit, harapan urip, utawa healthspan.

Syarat-syarat Jujur

  1. Pilot cilik: Kanthi 30 wong dibagi dadi telung grup, daya statistik sithik. Penulis uga ngajak supaya dilakukan uji coba gedhé.
  2. Marker surrogate: Aliran autophagy ing sel darah mung dadi jendela ora langsung babagan apa sing kedadéan ing jaringan liya.
  3. Mung sukarelawan sehat: Asil ora langsung bisa digeneralisasi kanggo wong kanthi diabetes, obesitas, utawa kondisi kronis liyane.
  4. Sponsor industri: Uji coba iki disponsori L‑Nutra Inc., produsen ProLon, lan ana afiliasi penulis karo L‑Nutra. Sanajan pernyataan ora ana konflik, pamaca kudu waspada lan ngarep‑arep replikasi mandiri.
  5. Penurunan bobot minangka konfunder: Saben grup sing diwatesi kalori bakal nyuda bobot, sing bisa dhewe‑dhewe ngowahi glukosa lan insulin.
  6. Latar belakang hewan: Klaim gedhé babagan FMD lan umur panjang asale saka riset tikus lan sel, dadi uji coba manungsa iki mung langkah awalan, dudu bukti final.

Sapa Kanggo Ngelakoni

Adhedhasar populasi sing diteliti, grup sing paling pas yaiku wong dewasa sehat umur setengah baya sing penasaran karo puasa periodik lan bisa nindakake kanthi aman. Amarga iki mung pilot 30 wong, anggep siklus FMD minangka eksperimen sing kudu dipantau, ora minangka protokol umur panjang sing wis dibuktekaké. Uji coba iki uga ora nemtokake frekuensi optimal kanggo siklus mengulang.

Sapa Sing Kudu Ngindari (utawa Rembugan Dhisik karo Dokter)

Uji coba iki mung kalebu peserta sehat, mula peringatan iki ditujokaké kanggo umum, ora saka temuan klinis. Sapa wae sing kalebu kategori ing ngisor iki kudu njaluk persetujuan medis sadurunge nyoba diet kalori sithik sawetara dina:

  • Wong sing lagi ngandhut utawa nyusoni.
  • Wong sing bobot kurang utawa duwe riwayat gangguan mangan.
  • Penderita diabetes tipe 1 utawa tipe 2, utamané sing nggunakake insulin utawa obat penurun glukosa.
  • Wong senior sing lemah lan duwé risiko kélangan otot.
  • Wong sing duwe penyakit ginjal, hati, utawa jantung sing signifikan, utawa sing nganggo obat sing dipengaruhi puasa.

Pelajaran Praktis

  • Dosis lan wektu: Ing trial iki, sinyal utama katon ing akhir intervensi kira‑kira 6 dina. Manfaat sing didelok hubungane karo mid‑diet, dudu mesthi tetep sawisé.
  • Aja kebablasan makna "autophagy": Sinyal sing diukur asalé saka sel imun ing darah, dudu saka sakabèhé organ.
  • Enteni replikasi: Diperlukan uji coba gedhé, independen, lan suwene luwih dawa sadurunge FMD bisa dianggep piranti autophagy sing teruji.

Kesimpulan: Iki salah siji uji coba manungsa pertama sing ngukur aliran autophagy nganggo FMD, lan sinyal awal cukup ngajeni. Nanging temuan iki isih adoh saka bukti sing pasti; luwih akeh riset dibutuhake.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
HW

Written by

Helix Ward

Helix Ward writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: conceptual metaphor. Palette: bold color field. A single steel bathroom-style analog tape measure, pulled taut and wrapped around a ripe, glossy yellow-orange pear lying on its side, with the tape's tip locked at the same unmarked point, suggesting a waistline that did not shrink. The pear sits on a saturated magenta seamless backdrop, shot from a low three-quarter angle with a shallow depth of field, the stem sharp and the background softly blurred. Hard but slightly diffused studio key light from upper left casts a crisp, short shadow in deeper magenta on the surface. A tiny electric green sticky dot marks the tape's end, with no numbers or writing visible. Mood: playful, skeptical, deadpan, scientific restraint rather than hype.
longevity

Rapamycin Mingguan Sajerone Taun: Aman, Nanging Apa Lemak Visceral Nggowahi?

BY REX MERIDIAN ·

Saben wong kepengin ngerti apa rapamycin mingguan bisa nyuda lemak visceral lan ningkatake healthspan. Uji coba PEARL maringi jawaban sing bisa ngagetaké. Sawisé 48 minggu ing wong diwasa sing sehat, asil utama babagan lemak visceral ora owah, nanging keamanané padha karo plasebo. Sawetara sinyal sekunder – kaya peningkatan massa lean lan rasa nyeri sing luwih sithik ing wanita sing nampa 10 mg, lan rasa kesejahteraan sing luwih apik ing dosis 5 mg – nuduhaké potensi manfaat. Nanging temuan iki asalé saka subkelompok lan laporan diri, rapamycin sing digunakake digawé khusus, lan durung ana bukti yèn iki nambah umur manungsa. Ing ngisor iki apa sing didhukung data lan apa sing ora.
A bright, minimalist editorial still life on a pale warm-white stone surface, shot from a slightly elevated three-quarter angle in soft natural window light. At center, a small amber glass supplement bottle with a matte cream label, unbranded, sits beside a few loose white capsules. A pair of weathered hands in a light oatmeal linen sleeve, belonging to an older adult, rests gently near the bottle, with a ceramic mug of tea just out of focus. To the right, a clean glass vial and a delicate glass beaker filled with clear liquid catch the light, hinting at laboratory research without any futuristic touch. A small paper notebook with a handwritten simple line graph rising in a gentle curve lies open nearby, along with a sharpened pencil. Scattered at the edges are soft sprigs of dried eucalyptus and a few pale sage-green leaves, adding an organic note. A faint, abstract molecular diagram printed in muted teal ink on a card leans against the bottle, subtle and graphic. The palette is calm and modern: warm ivory, sage green, soft teal, muted amber, and touches of dusty peach. Long, gentle shadows fall across the surface, and the shallow depth of field blurs the background into creamy neutral tones. The composition leaves generous negative space on the left third for headline text. The overall feel is a trendy health and science journal: clean, airy, trustworthy, and quietly sophisticated, with fine film-like grain and true-to-life color. Ultra-detailed, 16:9 landscape.
supplements

1.000 mg Nicotinamide Riboside saben dina nambah NAD+ ing sel getih kira‑kira 60 % ing wong diwasa tuwa, asil uji coba acak

BY DR. SYNAPSE ·

Uji coba crossover ing *Nature Communications* taun 2018 nyoba Nicotinamide Riboside (NR) 500 mg kaping loro saben dina (total 1.000 mg) nganti enem minggu marang wong diwasa sehat umur setengah umur nganti pra‑tua. Suplemen iki ditampa kanthi apik lan nambah NAD+ ing sel imun getih kira‑kira 60 % tinimbang plasebo. Peneliti uga nyatet sinyal wiwitan babagan tekanan darah sing luwih murah lan kekakuan arteri, nanging iki mung gagasan kanggo uji coba gedhé, ora bukti manfaat sing pasti. Artikel iki nerangake kenapa NAD+ dipikir turun bareng umur, apa sing ditindakake studi, lan apa sing ora bisa diceritakake babagan hasil penyakit utawa umur panjang.
Approach 4, conceptual metaphor, in palette D, bold color field. A single old brass pocket watch, photographed from a slightly high three-quarter angle, sits on a saturated mustard-yellow seamless backdrop. The watch case is cracked open and its glass is gone. One half of the gear train is clean and polished. The other half is corroded, with a dull green-black patina. A few fine droplets of clear liquid sit on the corroded gears, and one tiny electric green (#00e676) glint of oxidation shows at the edge of the damage. Hard but slightly diffused studio strobe from the upper left casts a crisp, short shadow on the yellow. The macro lens gives a shallow depth of field, with the sharpest focus on the split between healthy and damaged gears. The mood is cautionary, precise and quietly unsettling. No text or numerals appear on the dial.
longevity

Komponen Anti‑Aging Spermidine Duwe Efek Peteng ing Sel T Lawas

BY DR. SYNAPSE ·

Spermidine akeh dipromosikaké minangka poliamin anti‑penuaan, nanging panalitèn sel tikus anyar nemokaké yèn senyawa iki bisa ngganggu klompok sel imun lawas tartamtu. Ing sel CD49d‑ CD8+ sing mirip senesens, spermidine nyuda pernapasan mitokondria, ngilangi cadangan anti‑oksidan, lan ngowahi struktur mitokondria dadi pecah‑pecah. Sel tetanggan CD49d+ ora kena pengaruh. Sel saka tikus enom nanggapi kanthi cara sing beda, dadi umur dadi variabel penting. Iki kerja laboratorium, dudu bukti kerusakan ing manungsa, nanging nentang anggapan yèn spermidine migunani kanggo saben sel sing menua.
Approach: macro science. Palette: bold color field, warm. An extreme close-up of a human iris and pupil photographed from straight on, with a shallow depth of field. The sharp focus sits on the fine radial fibers of the iris, which are amber and honey brown. A single soft ring light reflects as a small crisp circle in the pupil. Behind the eye, out of focus, the skin and lashes fall away into a saturated mustard-yellow backdrop that fills the frame. A thin curved sliver of electric green light, like a reflection on the cornea's edge, is the only cool accent. The texture is real: tiny blood vessels in the sclera, individual lash hairs, moist highlights. The mood is clear, attentive and hopeful, clinical but warm. The composition is landscape, with the eye placed right of center and open space on the left.
supplements

Trio Polifenol Iki Nyilikake Deposit Drusen AMD Mata 13 % ing Uji Manungsa

BY NOVA CHEN ·

Deposit drusen minangka pratanda awal degenerasi makula amarga umur (AMD) lan cenderung nambah suwene wektu. Ing trial manungsa 24 sasi, kombinasi resveratrol, quercetin, lan curcumin (RQC) ngurangi volume drusen tengah nganti 13,4 %, nalika grup mung entuk curcumin ngalami kenaikan 6,9 %. Nanging penelitian iki open‑label, mung ana 38 pasien, lan ora ana kelompok plasebo. Bedane ketajaman visual (P = 0,08) ora signifikan sacara statistik, lan AREDS2 tetep dadi standar suplemen sing wis diterima. Ing ngisor iki angka‑angka sing dituduhake, apa sing ora dituduhake, lan apa sing kudu sampeyan takokake marang dokter mripatmu.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文